MFDS — authorised 21 December 1951
- Marketing authorisation holder: MERCK
- Status: likely_approved
🇰🇷 Cortifoam in South Korea
MFDS authorised Cortifoam on 21 December 1951
Marketing authorisation
Cortifoam in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Cortifoam approved in South Korea?
Yes. MFDS authorised it on 21 December 1951.
Who is the marketing authorisation holder for Cortifoam in South Korea?
MERCK holds the South Korean marketing authorisation.